Sunday, June 10

Clinical Trial Update | Science-in-Progress | Simultaneous Sessions III | Hematology-in-Focus Sessions | Simultaneous Sessions IV | Clinical Trial Update

CLINICAL TRIAL UPDATE

08.00-09.15 hours, Room: Mozart II

CHRONIC LYMPHOCYTIC LEUKEMIA

Chair: E. Kimby (Karolinska Institute, Stockholm, Sweden)
  • CLL TRIALS IN THE UK
    P. Hillmen (Leeds General Infirmary, Leeds, United Kingdom)
  • SPANISH TRIALS IN CLL: FCM COMBINATIONS
    F. Bosch (Hospital Clinic, Barcelona, Spain)
  • UPDATE ON THE TRIALS OF THE GERMAN CLL STUDY GROUP
    M. Hallek (University of Cologne, Cologne, Germany)
  • RECENT POLISH CLINICAL TRIALS WITH CLADRIBINE IN CHRONIC LYMPHOCYTIC LEUKEMIA
    T. Robak (Medical University of Lodz, Lodz, Poland)
  • TEH HOVON 68 CLL TRIAL: FLUDARABINE AND CYCLOPHOSPHAMIDE (CFC) VS FC + ALEMTUZUMAB IN BIOLOGICAL HIGH-RISK CLL. A PROGRESS REPORT
    C. Geisler (Rigshospitalet, Copenhagen, Denmark)


Top of page ]


EHA Executive Office, Westblaak 71, 3012 KE Rotterdam, The Netherlands | Phone: (+31) 10-4361760 | Email: